权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Identification of Genetic Suppressors of RNA Granules

RNA 颗粒遗传抑制因子的鉴定

基本信息

批准号：
10624879
负责人：
Natalie Gilks Farny
金额：
$ 7.36万
依托单位：
WORCESTER POLYTECHNIC INSTITUTE
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-06-01 至 2025-02-28
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10624879
关键词：
Address Affect Alzheimer&apos s Disease Amyotrophic Lateral Sclerosis Area Biological Biological Process Biology Cell Line Cells Cellular Stress Classification Clustered Regularly Interspaced Short Palindromic Repeats Cytoplasmic Granules Data Data Set Defect Disease Drosophila genus Embryonic Development Environmental Risk Factor Future Genes Genetic Genetic Determinism Germ Germ Cells Goals Hand Human Image Image Analysis Investigation Knock-out Knowledge Libraries Link Malignant Neoplasms Manuals Maps Messenger RNA Modeling Molecular Neurodegenerative Disorders Neurons Normal Cell Pathogenicity Pathway interactions Physiological Play Poly A Poly(A)+ RNA Polyadenylation Positioning Attribute Proteins Publishing RNA RNA Interference RNA Probes RNA interference screen Regulation Research Role TDP-43 aggregation Testing Therapeutic Visualization Work analysis pipeline automated image analysis biological adaptation to stress design genome-wide granule cell interest mRNA Export oligo (dT)programs protein TDP-43 protein aggregation screening stress granule tau aggregation whole genome

项目摘要

SUMMARY/ABSTRACT Polyadenylated (Poly(A)+) RNA containing cytoplasmic granules affect numerous biological functions and disease states. In normal cells, poly(A)+ granules take many forms, such as stress granules (SGs), processing bodies (PBs), neuronal granules, and germ cell granules. These granules affect mRNA localization, stability, and/or translational control under various physiological contexts. Pathogenic protein aggregates are a unifying feature of many neurodegenerative diseases (ND), including amyotrophic lateral sclerosis (ALS). The relationships between normal and pathogenic aggregates is still being deciphered, however clear links between the two are known. Thus, the co-aggregation of poly(A)+ RNA and protein in cytoplasmic granules under both normal and disease conditions is of broad biological importance. Yet, the genetic suppressors of poly(A)+ RNA granule formation have not been identified on a genome-wide scale. The long-term goal of this research program is to understand both the genetic and the environmental factors that regulate SG formation, and to understand how SGs relate to other types of aggregates and disease states. The overarching hypothesis is that genetic regulators of poly(A)+ RNA granule formation can be used to modulate RNA granule formation in specific biological and disease-related contexts. As a first step to testing this hypothesis, the primary objective of this proposal is to perform whole-genome screening to identify genes that suppress poly(A)+ RNA granule formation in both Drosophila and human cells. RNA granule suppressing genes, when depleted by RNAi, will cause the spontaneous formation of poly(A)+ RNA granules. To obtain the primary objective, the following two specific aims will be pursued. Aim 1: To identify genes that suppress poly(A)+ RNA granules in Drosophila S2R+ cells. An image analysis pipeline will be adapted to re-analyze images from a previously published whole-genome RNAi screen in Drosophila S2R+ cells (Farny et al., 2008). Aim 2: To examine the evolutionary conservation of poly(A)+ RNA granule suppressors in human cells. Using the primary screen hits from Aim 1 as a guide, a targeted CRISPR knockout library will be screened to identify human genes that suppress poly(A)+ RNA granules U2OS cells. This aim will also address the working hypothesis that genetic silencing of poly(A)+ RNA granule suppressors will result in an increase in endogenous TDP-43 aggregation in U2OS cells. The rationale for this approach is that, given the known links between poly(A)+ RNA granules and disease-causing aggregates, suppressors of poly(A)+ aggregation could be harnessed in future studies to suppress pathogenic aggregates. Given the known links between normal and pathogenic aggregate formation, understanding the genetic determinants of poly(A)+ RNA granule formation will provide new avenues of investigation for the genetic control of pathogenic aggregate formation. Thus the knowledge gained here will be of broad interest and importance.

摘要/摘要含有胞质颗粒的多腺苷化(Poly(A)+)RNA影响多种生物学功能和疾病状态。在正常细胞中，Poly(A)+颗粒有多种形式，如应激颗粒(SGS)，加工小体(PBS)、神经元颗粒和生殖细胞颗粒。这些颗粒影响mRNA的定位，稳定性，和/或在各种生理环境下的翻译控制。致病蛋白聚集体是一种许多神经退行性疾病(ND)的统一特征，包括肌萎缩侧索硬化症(ALS)。这个正常聚集体和致病聚集体之间的关系仍在被破译，尽管有明确的联系两者之间的关系是已知的。因此，Poly(A)+RNA和蛋白质在细胞质颗粒中共聚集在正常和疾病条件下都具有广泛的生物学重要性。然而，基因的抑制者 Poly(A)+RNA颗粒的形成还没有在全基因组范围内被确定。这样做的长期目标是研究计划是了解控制SG形成的遗传和环境因素，并了解SGS如何与其他类型的聚集体和疾病状态相关。最重要的是假设Poly(A)+RNA颗粒形成的遗传调节因子可用于调节RNA颗粒在特定的生物学和疾病相关背景下形成。作为检验这一假设的第一步，这项提议的主要目标是进行全基因组筛查，以识别抑制果蝇和人类细胞中Poly(A)+RNA颗粒的形成。RNA颗粒抑制基因，当被RNAi耗尽，会导致Poly(A)+RNA颗粒的自发形成。要获得主要的为了实现这一目标，将实现以下两个具体目标。目的1：鉴定抑制Poly(A)+RNA的基因果蝇S2R+细胞中的颗粒。一条图像分析管道将被改装成重新分析来自之前发表的在果蝇S2R+细胞中的全基因组RNAi屏幕(Farny等人，2008年)。目标2：实现研究人类细胞中聚(A)+RNA颗粒抑制子的进化保守性。使用主服务器来自Aim 1的屏幕点击作为指南，将筛选有针对性的CRISPR基因敲除文库来识别人类抑制Poly(A)+RNA颗粒的基因作用于U2OS细胞。这一目标也将解决工作假说 Poly(A)+RNA颗粒抑制因子的遗传沉默将导致内源性TDP-43的增加聚集在U2OS细胞中。这种方法的基本原理是，考虑到Poly(A)+之间的已知联系 RNA颗粒和致病聚集体，Poly(A)+聚集的抑制因子可以被利用未来抑制致病聚集物的研究。鉴于已知的正常和致病之间的联系聚集体形成，了解Poly(A)+RNA颗粒形成的遗传决定因素将提供病原聚集体形成的遗传控制研究新途径。因此，这一知识在这里取得的成果将具有广泛的兴趣和重要性。